Dopamine receptors in human brain: Autoradiographic distribution of D2 sites

Neuroscience - Tập 28 - Trang 275-290 - 1989
M. Camps1, R. Cortés1,2, B. Gueye1, A. Probst2, J.M. Palacios1
1Preclinical Research, Sandoz Ltd., CH-4002 Basle, Switzerland
2Institute of Pathology, Department of Neuropathology, University of Basle, Schönbeinstrasse 40, CH-4003 Basle ,Switzerland

Tài liệu tham khảo

Adolfsson, 1979, Postmortem distribution of dopamine and homovanillic acid in human brain, variations related to age and a review of the literature, J. Neurol. Trans., 45, 81, 10.1007/BF01250085 Alter, 1984, Brain dopamine and serotonin receptor sites revealed by digital substraction autoradiography, Science, 228, 597, 10.1126/science.2580352 Andén, 1972, Dopamine turnover in the corpus striatum and the limbic system after treatment with neuroleptic and anti-acetylcholine drugs, J. Pharm. Pharmac., 24, 905, 10.1111/j.2042-7158.1972.tb08912.x Andorn, 1984, Specific [3H]spiroperidol binding sites in human prefrontal cortex: potential site multiplicity and overall serotonin-like selectivity, Life Sci., 34, 2461, 10.1016/0024-3205(84)90282-0 Arnett, 1985, [18F]N-methylspiroperidol: the radioligand of choice for PET studies of the dopamine receptor in human brain, Life Sci., 36, 1359, 10.1016/0024-3205(85)90041-4 Baron, 1984, Dopaminergic receptor sites in human brain: positron emission tomography, Neurology, 35, 16, 10.1212/WNL.35.1.16 Baron, 1985, Progressive supranuclear palsy: loss of striatal dopamine receptors demonstrated in vivo by positron emission tomography, Lancet, 1163, 10.1016/S0140-6736(85)92470-5 Bird, 1982, Human brain postmortem studies of neurotransmitters and related markers, Vol. 2, 225 Bokobza, 1984, [3H]spiperone binding, dopamine and HVA concentrations in Parkinson's disease and supranuclear palsy, Eur. J. Pharmac., 99, 167, 10.1016/0014-2999(84)90238-3 Boyson, 1986, Quantitative autoradiographic localization of the D1 and D2 subtypes of dopamine receptors in rat brain, J. Neurosci., 6, 3177, 10.1523/JNEUROSCI.06-11-03177.1986 Camus, 1986, Autoradiographic localization and quantification of dopamine D2 receptors in normal human brain with [3H]N-n-propylnorapomorphine, Brain Res., 375, 135, 10.1016/0006-8993(86)90966-2 Carlsson, 1963, Effect of chlorpromazine and haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain, Acat Pharmac. Toxicol., 20, 140, 10.1111/j.1600-0773.1963.tb01730.x Charuchinda, 1987, Dopamine D2 receptors in the rat brain: autoradiographic visualization using a high affinity selective agonist ligand, J. Neurosci., 7, 1352, 10.1523/JNEUROSCI.07-05-01352.1987 Cortés, 1989, Dopamine receptors in human brain: autoradiographic distribution of dopamine D1 sites, Neuroscience, 28, 263, 10.1016/0306-4522(89)90178-4 Creese, 1976, Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs, Science, 192, 481, 10.1126/science.3854 Creese, 1978, Biochemical actions of neuroleptic drugs: Focus on the dopamine receptors, Vol. 10, 37 Creese, 1978, [3H]spiroperidol labels serotonin receptors in rat cerebral cortex and hippocampus, Eur. J. Pharmac., 49, 201, 10.1016/0014-2999(78)90080-8 Creese, 1978, Dopamine receptor binding regulated by guanine nucleotides, Molec. Pharmac., 16, 69 Creese, 1983, The classification of dopamine receptors: relationship to radioligand binding, A. Rev. Neurosci., 6, 43, 10.1146/annurev.ne.06.030183.000355 Creese, 1984, Agonist interactions with dopamine receptors: focus on radioligand binding studies, 43, 2779 Cross, 1983, Dopamaine D1 and D2 receptors in Huntington's disease, Eur. J. Pharmac., 88, 223, 10.1016/0014-2999(83)90009-2 Crow, 1977, The nucleus accumbens—possible site of antipsychotic action of neuroleptic drugs?, Psychol. Med., 7, 213, 10.1017/S0033291700029287 Crow, 1980, Molecular pathology of schizophrenia: more than one disease process?, Br. med. J., 280, 66, 10.1136/bmj.280.6207.66 Crow, 1982, Neurohumoral and structural changes in schizophrenia: two dimensions of pathology, 407 Dawson, 1985, D1 dopamine receptors in the rat brain: autoradiographic localization using [3H]SCH 23390, Eur. J. Pharmac., 108, 323, 10.1016/0014-2999(85)90458-3 De Keyser, 1985, Regional distribution of the dopamine D2 receptors in the mesotelencephalic dopamine neuron system of human brain, J. Neurol. Sci., 71, 119, 10.1016/0022-510X(85)90041-3 De Lean, 1982, Dopamine receptor of the anterior pituitary gland. Evidence for two affinity states discriminated by both agonists and antagonists, Molec. Pharmac., 22, 290 Dubois, 1985, Heterogeneous distribution of dopamine D2 receptors within the rat striatum as revealed by autoradiography of [3H]N-n-propylnorapomorphine binding sites, Neurosci. Lett., 57, 7, 10.1016/0304-3940(85)90032-1 Dubois, 1986, Autoradiographic distribution of the D1 agonist [3]SKF 38393, in the rat brain and spinal cord. Comparison with the distribution of D2 dopamine receptors, Neuroscience, 19, 125, 10.1016/0306-4522(86)90010-2 Enna, 1977, Neurotransmitter receptor binding: Regional distribution in human brain, J. Neurochem., 28, 233, 10.1111/j.1471-4159.1977.tb07733.x Farde, 1986, Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET, Science, 231, 258, 10.1126/science.2867601 Gaspar, 1983, Tyrosine hydroxylase and methionine-enkephalin in the human mesencephalon, J. neurol. Sci., 58, 247, 10.1016/0022-510X(83)90221-6 Gaspar, 1985, Catecholaminergic innervation of the septal area in man: immunocytochemical study using TH and DBH antibodies, J. comp. Neurol., 241, 12, 10.1002/cne.902410103 Gehlert, 1985, Dopamine receptors in the rat brain: quantitative autoradiographic localization using [3H]sulpiride, Neurochem. Int., 7, 717, 10.1016/0197-0186(85)90070-1 Hantraye, 1986, “ In vivo” visualization by positron emission tomography of the progressive striatal dopamine receptor damage occurring in MPTP-intoxicated non-human primates, Life Sci., 39, 1375, 10.1016/0024-3205(86)90336-X Hartvig, 1986, Receptor binding of N-[Methyl-11C]clozapine in the brain of Rhesus monkey studied by positron emission tomography (PET), Psychopharmacologia, 89, 248, 10.1007/BF00310638 Herkenham, 1986, Mismatches between receptor and transmitter localizations in the brain, 137 Iversen, 1975, Dopamine receptors in the brain, Science, 188, 1084, 10.1126/science.2976 Javoy-Agid, 1981, Distribution of catecholamines in the ventral mesencephalon of human brain with special reference to Parkinson's disease, J. Neurochem., 36, 2101, 10.1111/j.1471-4159.1981.tb10843.x Joyce, 1986, Age-related regional loss of caudate-putamen dopamine receptors revealed by quantitative autoradiography, Brain Res., 378, 158, 10.1016/0006-8993(86)90298-2 Joyce, 1986, Human striatal dopamine receptors are organized in compartments, 83, 8002 Kebabian, 1979, Multiple receptors for dopamine, Nature, 277, 93, 10.1038/277093a0 Klemm, 1979, Neuroleptic and dopamine receptors: autoradiographic localization of [3H]spiperone in rat brain, Brain Res., 169, 1, 10.1016/0006-8993(79)90369-X Köhler, 1984, Autoradiographic mapping of spirodecanone binding sites in the hippocampal region of the rat. Evidence for a localization on instrinsic neurons, Neurosci. Lett., 46, 179, 10.1016/0304-3940(84)90438-5 Köhler, 1986, Autoradiographic visualization of dopamine D2 receptors in the monkey brain using the selective benzamide drug [3H]raclopride, Neurosci. Lett., 66, 85, 10.1016/0304-3940(86)90170-9 Kuhar, 1978, Dopamine receptor binding in vivo: the feasibility of auto-radiographic studies, Life Sci., 22, 203, 10.1016/0024-3205(78)90538-6 Kuhar, 1985, The mismatch problem in receptor mapping studies, Trends Neurosci., 8, 190, 10.1016/0166-2236(85)90076-1 Leysen, 1978, Serotonergic component of neuroleptic receptors, Nature, 272, 168, 10.1038/272168a0 Liskowsky, 1985, D2 dopamine receptors in the frontal cortex of rat and human, Life Sci., 36, 1551, 10.1016/0024-3205(85)90379-0 Mackenzie, 1985, Chronic neuroleptic treatment increases D2 but not D1 receptors in rat striatum, Eur. J. Pharmac., 113, 159, 10.1016/0014-2999(85)90732-0 Martres, 1985, Widespread distribution of brain dopamine receptors evidenced with [125I]iodosulpride, a highly selective ligand, Science, 228, 752, 10.1126/science.3838821 Mazière, 1985, In vivo quantitative imaging of dopamine receptors in human brain, using positron emission tomography and [76Br]bromospiperone, Eur. J. Pharmac., 114, 267, 10.1016/0014-2999(85)90369-3 Miller, 1974, The action of neuroleptic drugs on dopamine-stimulated adenosine cyclic 3′,5′-monophosphate production in the neostriatum and limbic forebrain, Molec. Pharmac., 10, 759 Moor, 1978, Central catecholamine neuron systems: anatomy and physiology of the dopamine system, A. Rev. Neurosci., 1, 129, 10.1146/annurev.ne.01.030178.001021 Nakajima, 1984, [3H]RO 22-1319 (piquindone) binds to the D2 dopaminergic receptor subtype in a sodium-dependent manner, Molec. Pharmac., 26, 430 Nordmann, 1985, Octahydrobenzo[9]quinolines, potent dopamine agonists which show the relationship between ergolines and apomorphine, J. med. Chem., 28, 387, 10.1021/jm00381a017 O'Boyle, 1984, Loss of striatal dopamine receptors with ageing is selective for D2 but not D1 sites: association with increased non-specific binding on the D1 ligand [3H]piflutixol, Eur. J. Pharmac., 105, 171, 10.1016/0014-2999(84)90663-0 Olszewski, 1954 Palacios, 1980, Autoradiographic localization of GABA receptors in rat cerebellum, 77, 670 Palacios, 1981, [3H]spiperone binding sites in brain: autoradiographic localization of receptors, Brain Res., 213, 277, 10.1016/0006-8993(81)90234-1 Palacios, 1984, Catecholamine receptors, Vol. 3, 325 Palacios, 1986, Mapping receptors in the human brain, Trends Neurosci., 9, 284, 10.1016/0166-2236(86)90080-9 Palacios, 1987, Visualization of dopamine receptors: a progress review, 175 Palacios J. M., Camps M., Cortés R. and Charuchinda C. Characterization and distribution of brain dopamine receptors. In Advances in Parkinson's Disease and Movement Disorders (eds Jankovic S. and Tolosa E.). Urban & Schwarzenberg. Baltimore (in press). Pazos, 1987, Serotonin receptors in the human brain. IV. Autoradiographic mapping of serotonin-2 receptors, Neuroscience, 21, 123, 10.1016/0306-4522(87)90327-7 Pearson, 1983, Human brainstem catecholamine neuroal anatomy as indicated by immunocytochemistry with antibodies to tyrosine hydroxylase, Neuroscience, 8, 3, 10.1016/0306-4522(83)90023-4 Reynolds, 1981, The effects of lisuride and some other dopaminergic agonists on receptor binding in human brain, J. Neurol. Trans., 51, 107, 10.1007/BF01664008 Richelson, 1984, Antagonism by neuroleptics of neurotransmitter receptors of normal human brain in vitro, Eur. J. Pharmac., 103, 197, 10.1016/0014-2999(84)90478-3 Richfield, 1986, Properties of D2 dopamine receptor autoradiography: high percentage of high affinity agonist sites and increased nucleotide sensitivity in tissue sections, Brian Res., 383, 121, 10.1016/0006-8993(86)90013-2 Rinne, 1987, Muscarinic and dopaminergic receptors in the aging human brain, Brain Res., 404, 162, 10.1016/0006-8993(87)91367-9 Savasta, 1986, Autoradiographic localization of D1 dopamine receptors in the rat brain using [3H]SCH 23390, Brain Res., 375, 291, 10.1016/0006-8993(86)90749-3 Scatton, 1982, Evidence for the existence of a dopaminergic innervation of the rat and human hippocampal formation, 377 Scatton, 1985, Quantitative autoradiographic localization of dopamine receptors and uptake sites in the rat and human CNS, 351 Scatton, 1986, Autoradiographic visualization and quantification of dopamine receptors and uptake sites in the rat and human CNS Schultzberg, 1986, The mismatch problem in receptor autoradiography and the coexistence of multiple messengers, Trends Neurosci., 9, 109, 10.1016/0166-2236(86)90036-6 Schwartz, 1978, Dopamine receptors localized on cerebral cortical afferents to rat corpus striatum, Nature, 271, 766, 10.1038/271766a0 Seeman, 1976, Antipsychotic drug doses and neuroleptic/dopamine receptors, Nature, 261, 717, 10.1038/261717a0 Seeman, 1976, Dopamine receptors in human and calf brains, using [3H]apomorphine and an antipsychotic drug, 73, 4354 Seeman, 1980, Brain dopamine receptors, Pharmac. Rev., 32, 229 Severson, 1982, Age-correlated loss of dopaminergic binding sites in human basal ganglia, J. Neurochem., 39, 1623, 10.1111/j.1471-4159.1982.tb07996.x Severson, 1985, D3 dopamine receptors in aging mouse striatum: determination of high and low affinity agonist binding sites, J. Pharmac. exp. Ther., 233, 361 Sibley, 1982, Anterior pituitary dopamine receptors. Demonstration of interconvertible high and low affinity states of the D, dopamine receptor, J. biol. Chem., 257, 6351, 10.1016/S0021-9258(20)65148-1 Snyder, 1982, Schizophrenia (neurotransmitters and CNS disease), Lancet, ii, 970, 10.1016/S0140-6736(82)90167-2 Spokes, 1980, Neurochemical alterations in Huntington's chorea. A study of postmortem brain tissue, Brain, 103, 179, 10.1093/brain/103.1.179 Stefanini, 1980, Sodium-dependent interaction of benzamides with dopamine receptors, Brain Res., 198, 229, 10.1016/0006-8993(80)90360-1 Verney, 1985, Morphological evidence for a dopaminergic terminal field in the hippocampal formation of young and adult rat, Neuroscience, 14, 1039, 10.1016/0306-4522(85)90275-1 Wagner, 1983, Imaging dopamine receptors in the human brain by positron emission tomography, Science, 221, 1264, 10.1126/science.6604315 Whitehouse, 1984, Effects of postmortem delay and temperature on neurotransmitter receptor bind in a rat model of the human autopsy process, J. Neurochem., 43, 533, 10.1111/j.1471-4159.1984.tb00934.x Whitehouse, 1985, Neurotransmitter receptor alterations in Huntington's disease: autoradiographic and homogenate studies with special reference to benzodiazepine receptor complexes, Ann. Neurol., 18, 202, 10.1002/ana.410180207 Wong, 1984, Effects of age on dopamine and serotonin receptors measured by positron emission tomography in the living human brain, Science, 226, 1393, 10.1126/science.6334363 Wreggett, 1983, Agonist high and low affinity states of the D2 dopamine receptor in calf brain, Molec. Pharmac., 25, 10 Wreggett, 1984, The ternary complex model. Its properties and application to ligand interactions with the D2 dopamine receptor of the anterior pituitary gland, Molec. Pharmac., 26, 214